Literature DB >> 16176266

P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains.

Galina Radeva1, Jocelyne Perabo, Frances J Sharom.   

Abstract

P-glycoprotein (Pgp), a member of the ATP-binding cassette (ABC) superfamily responsible for the ATP-driven extrusion of diverse hydrophobic molecules from cells, is a cause of multidrug resistance in human tumours. Pgp can also operate as a phospholipid and glycosphingolipid flippase, and has been functionally linked to cholesterol, suggesting that it might be associated with sphingolipid-cholesterol microdomains in cell membranes. We have used nonionic detergent extraction and density gradient centrifugation of extracts from the multidrug-resistant Chinese hamster ovary cell line, CH(R)B30, to address this question. Our data indicate that Pgp is localized in intermediate-density membrane microdomains different from classical lipid rafts enriched in Src-family kinases. We demonstrate that Brij-96 can selectively isolate the Pgp domains, separating them from the caveolar and classical lipid rafts. Pgp was found entirely in the Brij-96-insoluble domains, and only partially in the Triton X-100-insoluble membrane microdomains. We studied the sensitivity of these domains to cholesterol removal, as well as their relationship to GM(1) ganglioside- and caveolin-1-enriched caveolar domains. We found that the buoyant density of the Brij-96-based Pgp-containing microdomains was sensitive to cholesterol removal by methyl-beta-cyclodextrin. The Brij-96 domains retained their structural integrity after cholesterol depletion while, in contrast, the Triton X-100-based caveolin-1/GM(1) microdomains did not. Using confocal fluorescence microscopy, we determined that caveolin-1 and GM(1) colocalized, while Pgp and caveolin-1, or Pgp and GM(1), did not. Our results suggest that Pgp does not interact directly with caveolin-1, and is localized in intermediate-density domains, distinct from classical lipid rafts and caveolae, which can be isolated using Brij-96.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176266     DOI: 10.1111/j.1742-4658.2005.04905.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  19 in total

Review 1.  Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells.

Authors:  Xing Liu; Qing-Hai Zhang; Guang-Hui Yi
Journal:  Mol Cell Biochem       Date:  2011-11-24       Impact factor: 3.396

Review 2.  Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?

Authors:  Wing-Kee Lee; Richard N Kolesnick
Journal:  Cell Signal       Date:  2017-07-04       Impact factor: 4.315

3.  Extensive sphingolipid depletion does not affect lipid raft integrity or lipid raft localization and efflux function of the ABC transporter MRP1.

Authors:  Karin Klappe; Anne-Jan Dijkhuis; Ina Hummel; Annie van Dam; Pavlina T Ivanova; Stephen B Milne; David S Myers; H Alex Brown; Hjalmar Permentier; Jan W Kok
Journal:  Biochem J       Date:  2010-09-15       Impact factor: 3.857

4.  The ontogeny of P-glycoprotein in the developing human blood-brain barrier: implication for opioid toxicity in neonates.

Authors:  Jessica Lam; Stephanie Baello; Majid Iqbal; Lauren E Kelly; Patrick T Shannon; David Chitayat; Stephen G Matthews; Gideon Koren
Journal:  Pediatr Res       Date:  2015-06-18       Impact factor: 3.756

5.  D1-like receptors regulate NADPH oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells.

Authors:  Hewang Li; Weixing Han; Van Anthony M Villar; Lindsay B Keever; Quansheng Lu; Ulrich Hopfer; Mark T Quinn; Robin A Felder; Pedro A Jose; Peiying Yu
Journal:  Hypertension       Date:  2009-04-20       Impact factor: 10.190

6.  A new N-terminal recognition domain in caveolin-1 interacts with sterol carrier protein-2 (SCP-2).

Authors:  Rebecca D Parr; Gregory G Martin; Heather A Hostetler; Megan E Schroeder; Kiran D Mir; Ann B Kier; Judith M Ball; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2007-06-20       Impact factor: 3.162

7.  Acute pain alters P-glycoprotein-containing protein complexes in rat cerebral microvessels: Implications for P-glycoprotein trafficking.

Authors:  Margaret E Tome; Chelsea K Jarvis; Charles P Schaefer; Leigh M Jacobs; Joseph M Herndon; Kristen C Hunn; Nathan B Arkwright; Kathryn L Kellohen; Peyton C Mierau; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-22       Impact factor: 6.200

8.  Evaluation of the contribution of the ATP binding cassette transporter, P-glycoprotein, to in vivo cholesterol homeostasis.

Authors:  Stephen D Lee; Sheila J Thornton; Kristina Sachs-Barrable; Jenny H Kim; Kishor M Wasan
Journal:  Mol Pharm       Date:  2013-06-24       Impact factor: 4.939

9.  Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cells.

Authors:  Yu Zhong; Bernhard Hennig; Michal Toborek
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-30       Impact factor: 6.200

Review 10.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.